Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;142(3):512-8.
doi: 10.1111/j.1365-2249.2005.02936.x.

The association of anti-phospholipid antibodies with parity in placental malaria

Affiliations

The association of anti-phospholipid antibodies with parity in placental malaria

S Owens et al. Clin Exp Immunol. 2005 Dec.

Abstract

Anti-phospholipid antibodies (aPL) are autoantibodies associated with both infections and the pathogenesis of certain pregnancy complications. In the latter, but not the former, aPL are dependent on a co-factor, beta(2) glycoprotein I (beta2GPI), which can also be used as an antigen for detection of such aPL in pregnancy. A cross-sectional study was carried out on serum samples from Kumasi, Ghana, to determine the occurrence and beta2GPI-dependence of aPL in placental malaria. Anti-cardiolipin, anti-phosphatidylserine and anti-beta2GPI enzyme-linked immunosorbent assays (ELISAs) were performed on sera from 103 HIV-non-infected gravid women. Placental malaria, both active and past infection, was diagnosed in 33/103 (32%) based on placental histology. In multiparae, beta2GPI-independent IgM antibodies to cardiolipin (P = 0.018) and phosphatidylserine (P = 0.009) were observed, which were most pronounced in past placental malaria infection. In primiparae, no association emerged between aPL and placental malaria. Trends for improved clinical parameters were identified in infected women with levels of anti-cardiolipin beyond the 99th multiple of the median for a healthy, non-malarious population. This study in placental malaria reports parity associations of beta2GPI-independent aPL profiles, and does not support a role for beta2GPI-dependent aPL. It is of significance in the context of the known parity differences in pregnancy malaria immunity.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
IgG anti-phospholipid antibody (aPL) responses to placental malaria infection according to parity. Concentrations expressed as multiples of the median (MOM). Bar and box represent median and interquartile range. Whisker represents range of values within 1·5 box lengths of median.
Fig. 2
Fig. 2
IgM anti-phospholipid antibody (aPL) responses to placental malaria infection according to parity. Concentrations expressed as multiples of the median (MOM). Bar and box represent median and interquartile range. Whisker represents range of values within 1·5 box lengths of median.

Similar articles

Cited by

References

    1. Jakobsen PH, Morris-Jones SD, Hviid L, et al. Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology. 1993;79:653–7. - PMC - PubMed
    1. Consigny PH, Cauquelin B, Agnamey P, et al. High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol. 2002;127:158–64. - PMC - PubMed
    1. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus. 1992;1:75–81. - PubMed
    1. Chamley LW. Antiphospholipid antibodies: biological basis and prospects for treatment. J Reprod Immunol. 2002;57:185–202. - PubMed
    1. Kutteh WH, Rote NS, Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol. 1999;41:133–52. - PubMed

Publication types

MeSH terms